scholarly article | Q13442814 |
P50 | author | Isabelle P Oswald | Q57143285 |
Marc Maresca | Q57317194 | ||
Josette Perrier | Q88060396 | ||
Eric Di Pasquale | Q97904162 | ||
Cendrine Nicoletti | Q97904165 | ||
Fabien Graziani | Q114318812 | ||
Ange Pujol | Q114318813 | ||
P2093 | author name string | Philippe Pinton | |
Loriane Armand | |||
P2860 | cites work | Impacts of the feed contaminant deoxynivalenol on the intestine of monogastric animals: poultry and swine. | Q38263480 |
Role of nitric oxide in host defense in murine salmonellosis as a function of its antibacterial and antiapoptotic activities | Q39655032 | ||
Protein expression profiling of mouse thymoma cells upon exposure to the trichothecene deoxynivalenol (DON): Implications for its mechanism of action | Q39673600 | ||
Deoxynivalenol and nivalenol inhibit lipopolysaccharide-induced nitric oxide production by mouse macrophage cells | Q39783299 | ||
Rapamycin down-regulates inducible nitric oxide synthase by inducing proteasomal degradation | Q39844856 | ||
Zinc protoporphyrin inhibition of lipopolysaccharide-, lipoteichoic acid-, and peptidoglycan-induced nitric oxide production through stimulating iNOS protein ubiquitination | Q39859434 | ||
Modulation of nitric oxide, hydrogen peroxide and cytokine production in a clonal macrophage model by the trichothecene vomitoxin (deoxynivalenol). | Q41046704 | ||
Bacterial induction of inducible nitric oxide synthase in cultured human intestinal epithelial cells | Q41071682 | ||
Deoxynivalenol alone or in combination with nivalenol and zearalenone induce systemic histological changes in pigs. | Q41734918 | ||
The food-associated fungal neurotoxin ochratoxin A inhibits the absorption of glutamate by astrocytes through a decrease in cell surface expression of the excitatory amino-acid transporters GLAST and GLT-1. | Q43014431 | ||
Chronic ingestion of deoxynivalenol and fumonisin, alone or in interaction, induces morphological and immunological changes in the intestine of piglets. | Q43414760 | ||
Both direct and indirect effects account for the pro-inflammatory activity of enteropathogenic mycotoxins on the human intestinal epithelium: stimulation of interleukin-8 secretion, potentiation of interleukin-1beta effect and increase in the transe | Q46727480 | ||
The ribotoxin deoxynivalenol affects the viability and functions of glial cells. | Q49059266 | ||
Enteropathogenic Escherichia coli (EPEC) effector-mediated suppression of antimicrobial nitric oxide production in a small intestinal epithelial model system. | Q54474693 | ||
Innate immunity in the small intestine | Q57253397 | ||
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
The impact of Fusarium mycotoxins on human and animal host susceptibility to infectious diseases | Q27004696 | ||
Deoxynivalenol as a new factor in the persistence of intestinal inflammatory diseases: an emerging hypothesis through possible modulation of Th17-mediated response | Q27321054 | ||
Effect of deoxynivalenol and other Type B trichothecenes on the intestine: a review | Q33736548 | ||
The intestinal epithelium is an integral component of a communications network | Q33808278 | ||
Proteomic analysis of the effects of the immunomodulatory mycotoxin deoxynivalenol | Q33861765 | ||
Modulation of inducible nitric oxide synthase expression by the attaching and effacing bacterial pathogen citrobacter rodentium in infected mice | Q34184792 | ||
Paradigms of protein degradation by the proteasome | Q34410240 | ||
Evaluation of an oral subchronic exposure of deoxynivalenol on the composition of human gut microbiota in a model of human microbiota-associated rats | Q35049126 | ||
Comparison of anorectic and emetic potencies of deoxynivalenol (vomitoxin) to the plant metabolite deoxynivalenol-3-glucoside and synthetic deoxynivalenol derivatives EN139528 and EN139544. | Q35102616 | ||
Effects of oral exposure to naturally-occurring and synthetic deoxynivalenol congeners on proinflammatory cytokine and chemokine mRNA expression in the mouse. | Q35534227 | ||
Inhibition of nitric oxide and inflammatory cytokines in LPS-stimulated murine macrophages by resveratrol, a potent proteasome inhibitor | Q36086859 | ||
The effects of mycotoxins, fungal food contaminants, on the intestinal epithelial cell-derived innate immune response. | Q36250149 | ||
Mixtures in the real world: the importance of plant self-defense toxicants, mycotoxins, and the human diet | Q36732776 | ||
The toxicological impacts of the Fusarium mycotoxin, deoxynivalenol, in poultry flocks with special reference to immunotoxicity | Q37005507 | ||
The expression of type-1 and type-2 nitric oxide synthase in selected tissues of the gastrointestinal tract during mixed mycotoxicosis | Q37357904 | ||
Some food-associated mycotoxins as potential risk factors in humans predisposed to chronic intestinal inflammatory diseases. | Q37751087 | ||
Deoxynivalenol: mechanisms of action, human exposure, and toxicological relevance | Q37783539 | ||
Epithelial barrier biology: good fences make good neighbours | Q37951617 | ||
Trichothecene toxicity in eukaryotes: cellular and molecular mechanisms in plants and animals | Q38070336 | ||
From the gut to the brain: journey and pathophysiological effects of the food-associated trichothecene mycotoxin deoxynivalenol | Q38101247 | ||
Public health impacts of foodborne mycotoxins | Q38178306 | ||
P433 | issue | 2 | |
P921 | main subject | deoxynivalenol | Q420518 |
P304 | page(s) | 372-382 | |
P577 | publication date | 2015-03-12 | |
P1433 | published in | Toxicological Sciences | Q2446966 |
P1476 | title | The Food-Associated Ribotoxin Deoxynivalenol Modulates Inducible NO Synthase in Human Intestinal Cell Model | |
P478 | volume | 145 |
Q36560606 | Barrier protection via Toll-like receptor 2 signaling in porcine intestinal epithelial cells damaged by deoxynivalnol |
Q35894734 | Biochemical Characterization of a Recombinant UDP-glucosyltransferase from Rice and Enzymatic Production of Deoxynivalenol-3-O-β-D-glucoside |
Q90581245 | Deoxynivalenol induces structural alterations in epidermoid carcinoma cells A431 and impairs the response to biomechanical stimulation |
Q47219798 | Detoxification of Fusarium-contaminated maize with sodium sulphite - in vivo efficacy with special emphasis on mycotoxin residues and piglet health |
Q94496424 | Dynamic Malignant Wave of Ribosome-Insulted Gut Niche via the Wnt-CTGF/CCN2 Circuit |
Q64102203 | Effect of Strains on Intestinal Barrier Function and Inflammatory Response |
Q93089695 | Effects of Saccharomyces cerevisiae on alleviating cytotoxicity of porcine jejunal epithelia cells induced by deoxynivalenol |
Q37641144 | Forthcoming Challenges in Mycotoxins Toxicology Research for Safer Food-A Need for Multi-Omics Approach |
Q37209011 | Hydrolytic Fate of 3/15-Acetyldeoxynivalenol in Humans: Specific Deacetylation by the Small Intestine and Liver Revealed Using in Vitro and ex Vivo Approaches |
Q36401480 | Molecular Mechanisms of Lipoic Acid Protection against Aflatoxin B₁-Induced Liver Oxidative Damage and Inflammatory Responses in Broilers |
Q47161667 | Nitric oxide mediates apoptosis and mitochondrial dysfunction and plays a role in growth hormone deficiency by nivalenol in GH3 cells |
Q37378866 | Phosphoproteome Analysis Reveals the Molecular Mechanisms Underlying Deoxynivalenol-Induced Intestinal Toxicity in IPEC-J2 Cells |
Q47160469 | Risks to human and animal health related to the presence of deoxynivalenol and its acetylated and modified forms in food and feed |
Q37700056 | The Food Contaminant Deoxynivalenol Exacerbates the Genotoxicity of Gut Microbiota |
Search more.